Progentec
Eldon brings over 30 years of experience in biochemistry, toxicology and human genetics. He co-founded InterGenetics Inc., and served as its VP, CSO and COO and raised more than $30M in financing and grants over time. He led a team that developed OncoVue® – a proprietary test for breast cancer . Eldon graduated magna cum laude from Texas A&M University with a BS in Biochemistry and an MS in Genetics. He holds a PhD in Biochemistry from Louisiana State University and completed Postdoctoral studies at the University of Cincinnati.
Progentec
2 followers
Progentec is a next-gen diagnostics company developing blood-based and digital biomarkers to transform the care of people living with autoimmune diseases